UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Alexion is implementing good security practices.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases.
This report shows a preliminary security rating for Alexion. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The California Consumer Privacy Act (CCPA) or AB 375 is a new law that became effective on January ...
The unfortunate truth is outsourcing to third-parties introduces significant cyber risk. The news ...
Compare Alexion's security performance with other companies